Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

VM Pharma (TrkA Program)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

VM-902A pharmaceutical product. The asset is used to develop VM-902A which is orally bioavailable, peripherally acting and allosteric selective tropomyosin receptor kinase for recovering of many diseases in USA.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 45535 Northport Loop East
  • Fremont, CA 94538
  • United States

VM Pharma (TrkA Program) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore VM Pharma (TrkA Program)‘s full profile, request access.

Request full access to PitchBook